BioCentury
ARTICLE | Company News

Celtrix, Genentech deal

March 22, 1993 8:00 AM UTC

CTRX received nonexclusive rights for ophthalmological uses and exclusive rights for local dermal wound healing plus nonexclusive rights for the systemic treatment of autoimmune diseases, osteoporosis...